Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Radiation can cause cancer and non-cancer outcomes, but it does not cause every type of cancer and non-cancer outcome.”
Some of the most common and deadly cancers receive little attention and resources.
Targeted therapy combination reduced the risk of disease progression or death by 65% in a randomized study.
Phil Catudal credits his early cancer experience with his motivational approach to wellness.
Using mouse models, the study focused on why asparaginase—a natural enzyme used as a drug to treat the blood cancer—doesn’t always work.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
The professional wrestler has lived with the cancer since age 22.
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
Venclexta alone or in combination with Rituxan improved progression-free survival in patients with chronic lymphocytic leukemia.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
A look back at some of the major news stories we covered this year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.